83 related articles for article (PubMed ID: 20458435)
1. Protein Z-dependent protease inhibitor (ZPI) is present in loco in human breast cancer tissue.
Sierko E; Wojtukiewicz MZ; Ostrowska-Cichocka K; Zimnoch L
Thromb Haemost; 2010 Jul; 104(1):183-5. PubMed ID: 20458435
[No Abstract] [Full Text] [Related]
2. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.
Montanari M; Boninsegna A; Faraglia B; Coco C; Giordano A; Cittadini A; Sgambato A
J Cell Physiol; 2005 Jan; 202(1):215-22. PubMed ID: 15389519
[TBL] [Abstract][Full Text] [Related]
3. BigH3 protein expression as a marker for breast cancer.
Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of non-tumoral breast tissue.
Costa GG; Kaviski R; Souza LE; Urban CA; Lima RS; Cavalli IJ; Ribeiro EM
Genet Mol Res; 2011 Oct; 10(4):2430-42. PubMed ID: 21968807
[TBL] [Abstract][Full Text] [Related]
5. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
6. Detection of human epidermal growth factor receptor 2 protein and gene in fine needle aspiration cytology specimens and tissue sections from invasive breast cancer: can cytology specimens take the place of tissue sections?
Sumiyoshi K; Shibayama Y; Akashi S; Nohara T; Iwamoto M; Kobayashi T; Nishimura H; Yoshinaka R; Harada T; Tanigawa N
Oncol Rep; 2006 Apr; 15(4):803-8. PubMed ID: 16525662
[TBL] [Abstract][Full Text] [Related]
7. Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer.
Sierko E; Wojtukiewicz MZ; Zimnoch L; Tokajuk P; Ostrowska-Cichocka K; Kisiel W
Ann Hematol; 2014 May; 93(5):779-84. PubMed ID: 24158387
[TBL] [Abstract][Full Text] [Related]
8. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.
Sansone P; Storci G; Tavolari S; Guarnieri T; Giovannini C; Taffurelli M; Ceccarelli C; Santini D; Paterini P; Marcu KB; Chieco P; Bonafè M
J Clin Invest; 2007 Dec; 117(12):3988-4002. PubMed ID: 18060036
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of differentiation is overexpressed with progression of benign to malignant lesions and related with carcinoembryonic antigen-related cell adhesion molecule 1 distribution in mammary glands.
Liu Q; Yang YM; Zhang QH; Zhang TG; Zhou Q; Zhou CJ
Ann Diagn Pathol; 2011 Feb; 15(1):30-6. PubMed ID: 21106423
[TBL] [Abstract][Full Text] [Related]
10. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
11. Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells.
Sierko E; Wojtukiewicz MZ; Zimnoch L; Tokajuk P; Ostrowska-Cichocka K; Kisiel W
Thromb Res; 2012 Apr; 129(4):e112-8. PubMed ID: 22424030
[TBL] [Abstract][Full Text] [Related]
12. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.
Miki Y; Suzuki T; Kitada K; Yabuki N; Shibuya R; Moriya T; Ishida T; Ohuchi N; Blumberg B; Sasano H
Cancer Res; 2006 Jan; 66(1):535-42. PubMed ID: 16397270
[TBL] [Abstract][Full Text] [Related]
13. Comparison of liquid based cytology and histology for the evaluation of HER-2 status using immunostaining and CISH in breast carcinoma.
Sartelet H; Lagonotte E; Lorenzato M; Duval I; Lechki C; Rigaud C; Cucherousset J; Durlach A; Graesslin O; Abboud P; Doco-Fenzy M; Quereux C; Costa B; Polette M; Munck JN; Birembaut P
J Clin Pathol; 2005 Aug; 58(8):864-71. PubMed ID: 16049291
[TBL] [Abstract][Full Text] [Related]
14. Expression of tissue factor pathway inhibitor (TFPI) in human breast and colon cancer tissue.
Sierko E; Wojtukiewicz MZ; Zimnoch L; Kisiel W
Thromb Haemost; 2010 Jan; 103(1):198-204. PubMed ID: 20062932
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
16. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
18. Protein Z is present in human breast cancer tissue.
Sierko E; Wojtukiewicz MZ; Zimnoch L; Tokajuk P; Kisiel W
Int J Hematol; 2011 May; 93(5):681-683. PubMed ID: 21479979
[No Abstract] [Full Text] [Related]
19. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
20. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
